MDGL
Madrigal Pharmaceuticals Inc
Price:  
312.77 
USD
Volume:  
207,499.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MDGL Probability of Bankruptcy

The Probability of Bankruptcy of Madrigal Pharmaceuticals Inc (MDGL) is 8.38% . This number represents the probability that MDGL will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating MDGL's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

MDGL - ESG ratings

ESG ratings are directly linked to the cost of capital and MDGL's ability to raise funding, both of which can significantly affect the probability of Madrigal Pharmaceuticals Inc going bankrupt.

ESG Score 30.91
Environment Score 31.86
Social Score 42.74
Governance Score 18.12
Returns
Historical Returns (5 day) -1.79%
Historical Returns (MTD) -4.70%
Historical Returns (YTD) 35.18%
Historical Returns (13 week) 32.70%
Historical Returns (26 week) 29.59%
Historical Returns (52 week) 48.63%
Efficiency
Asset Turnover 0.12
Receiveable Turnover 296.00
Gross Margin
Operating Margin -363.01%
Pretax Margin -337.10%
Net Margin -337.10%
Return on Asset (ROA) -78.51
Return on Equity (ROE) -128.60
Return on Investments (ROI) -97.24
Price Metrics
Market Cap (M) 6,821.51
Enterprise Value (M)
52 Week High 368.29
52 Week Low 168.80
Beta 0.56
Average Volume (10 day) 0.30
Average Volume (3 month) 0.37
Price / Earnings (P/E)
Price / Sales (P/S) 88.81
Earnings
EPS -25.07
Revenue CAGR (5 year)
Risk
Current Ratio 9.39
Quick Ratio 9.26